Cargando…
The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
Poor oocyte quality is a main concern for decreased reproductive outcomes in women with polycystic ovarian syndrome (PCOS) during controlled ovarian hyperstimulation (COH). A primary way to improve oocyte quality is to optimize the COH protocol. It was demonstrated that the viable embryo rate per oo...
Autores principales: | Zhu, Xiuxian, Ye, Hongjuan, Fu, Yonglun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956813/ https://www.ncbi.nlm.nih.gov/pubmed/27428219 http://dx.doi.org/10.1097/MD.0000000000004193 |
Ejemplares similares
-
Utrogestan as an Effective Oral Alternative for Preventing Premature Luteinizing Hormone Surges in Women Undergoing Controlled Ovarian Hyperstimulation for In Vitro Fertilization
por: Zhu, Xiuxian, et al.
Publicado: (2015) -
A case report of Ovarian hyperstimulation syndrome and corpus luteum rupture in twin pregnancies with IVF-ET
por: Luo, Yunliao, et al.
Publicado: (2023) -
Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
por: Sun, Bo, et al.
Publicado: (2021) -
Prediction of ovarian hyperstimulation syndrome in coasted patients in an IVF/ICSI program
por: Aljawoan, Fatimah Y, et al.
Publicado: (2012) -
Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET
por: Zheng, Xiangqin, et al.
Publicado: (2017)